A significant advance in cancer research is occurring with the use of nanobodies to reactivate mutated p53. This crucial tumor protector protein is frequently disabled in various kinds of cancer, resulting uncontrolled https://bookmarkport.com/story24834394/mini-antibodies-reactivate-the-p53-protein-the-promising-pathway-for-cancer-management